Literature DB >> 35697790

Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.

Gehong Dong1,2,3, Xuxiang Liu1, Lifu Wang4, Wenjuan Yin5,6, Alyssa Bouska7, Qiang Gong1, Kunal Shetty1, Lu Chen8, Sunandini Sharma7, Jibin Zhang1, Carmen Lome-Maldonado9, Leticia Quintanilla-Martinez10, Yuping Li1, Joo Y Song1, Wenyan Zhang11, Yunfei Shi1,12, Jinhui Wang13, Lingbo Kong1, Xiwei Wu13, Jingwen Wang14, Hong-Gang Liu3, Lingfei Kong4, Wenyong Sun5,6, Weiping Liu11, Lili Wang15, Timothy W McKeithan1, Javeed Iqbal16, Wing C Chan17.   

Abstract

Extra-nodal NK/T-cell lymphoma, nasal type (ENKTCL) is a highly aggressive Epstein-Barr virus associated lymphoma, typically presenting in the nasal and paranasal areas. We assembled a large series of ENKTCL (n = 209) for comprehensive genomic analysis and correlative clinical study. The International Lymphoma Prognostic Index (IPI), site of disease, stage, lymphadenopathy, and hepatomegaly were associated with overall survival. Genetic analysis revealed frequent oncogenic activation of the JAK/STAT3 pathway and alterations in tumor suppressor genes (TSGs) and genes associated with epigenomic regulation. Integrated genomic analysis including recurrent mutations and genomic copy number alterations using consensus clustering identified seven distinct genetic clusters that were associated with different clinical outcomes, thus constituting previously unrecognized risk groups. The genetic profiles of ENTKCLs from Asian and Hispanic ethnic groups showed striking similarity, indicating shared pathogenetic mechanism and tumor evolution. Interestingly, we discovered a novel functional cooperation between activating STAT3 mutations and loss of the TSG, PRDM1, in promoting NK-cell growth and survival. This study provides a genetic roadmap for further analysis and facilitates investigation of actionable therapeutic opportunities in this aggressive lymphoma.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35697790     DOI: 10.1038/s41375-022-01623-z

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


  56 in total

1.  Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.

Authors:  Tawatchai Pongpruttipan; Sanya Sukpanichnant; Thamathorn Assanasen; Pongsak Wannakrairot; Paisarn Boonsakan; Wasana Kanoksil; Kanita Kayasut; Winyou Mitarnun; Archrob Khuhapinant; Udomsak Bunworasate; Teeraya Puavilai; Anan Bedavanija; Adriana Garcia-Herrera; Elias Campo; James R Cook; John Choi; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

2.  Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.

Authors:  J Iqbal; D D Weisenburger; A Chowdhury; M Y Tsai; G Srivastava; T C Greiner; C Kucuk; K Deffenbacher; J Vose; L Smith; W Y Au; S Nakamura; M Seto; J Delabie; F Berger; F Loong; Y-H Ko; I Sng; X Liu; T P Loughran; J Armitage; W C Chan
Journal:  Leukemia       Date:  2010-11-05       Impact factor: 11.528

3.  Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.

Authors:  A K Chiang; Q Tao; G Srivastava; F C Ho
Journal:  Int J Cancer       Date:  1996-11-04       Impact factor: 7.396

4.  Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.

Authors:  Jie-Yang Jhuang; Sheng-Tsung Chang; Shih-Feng Weng; Shien-Tung Pan; Pei-Yi Chu; Pin-Pen Hsieh; Chih-Hsin Wei; Shih-Cheng Chou; Chiew-Loon Koo; Chih-Jung Chen; Jeng-Dong Hsu; Shih-Sung Chuang
Journal:  Hum Pathol       Date:  2014-11-26       Impact factor: 3.466

5.  Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.

Authors:  Y H Ko; H J Ree; W S Kim; W H Choi; W S Moon; S W Kim
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

6.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yenlin Huang; Aurélien de Reyniès; Laurence de Leval; Bouchra Ghazi; Nadine Martin-Garcia; Marion Travert; Jacques Bosq; Josette Brière; Barbara Petit; Emilie Thomas; Paul Coppo; Teresa Marafioti; Jean-François Emile; Marie-Hélène Delfau-Larue; Christian Schmitt; Philippe Gaulard
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

7.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

8.  DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.

Authors:  Xin Li; Yingying Cui; Zhenchang Sun; Lei Zhang; Ling Li; Xinhua Wang; Jingjing Wu; Xiaorui Fu; Wang Ma; Xudong Zhang; Yu Chang; Feifei Nan; Wencai Li; Liping Su; Jinghua Wang; Hongwei Xue; Mingzhi Zhang
Journal:  Clin Cancer Res       Date:  2016-04-08       Impact factor: 12.531

9.  Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

Authors:  Wing-yan Au; Dennis D Weisenburger; Tanin Intragumtornchai; Shigeo Nakamura; Won-Seog Kim; Ivy Sng; Julie Vose; James O Armitage; Raymond Liang
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113

10.  Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma.

Authors:  Yong Yang; Jian-Zhong Cao; Sheng-Min Lan; Jun-Xin Wu; Tao Wu; Su-Yu Zhu; Li-Ting Qian; Xiao-Rong Hou; Fu-Quan Zhang; Yu-Jing Zhang; Yuan Zhu; Li-Ming Xu; Zhi-Yong Yuan; Shu-Nan Qi; Ye-Xiong Li
Journal:  JAMA Oncol       Date:  2017-01-01       Impact factor: 31.777

View more
  1 in total

Review 1.  New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Authors:  Leticia Quintanilla-Martinez; Steven H Swerdlow; Thomas Tousseyn; Carlos Barrionuevo; Shigeo Nakamura; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.